For our community members affected by GAN
We wanted to share news we’ve received with our community members affected by giant axonal neuropathy (GAN). Taysha has made the difficult decision to discontinue the development of the investigational gene therapy candidate, TSHA-120, for the treatment of GAN.
To read Taysha’s letter to the GAN community: Taysha Letter to the GAN Community
